Research Funding Opportunities
The National Human Genome Research Institute supports research and training and career development opportunities in support of its research mission which is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.
Overview
To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR), a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.
For how NHGRI will treat new and non-competing applications, see the NHGRI Funding Policy.
-
Overview
To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR), a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.
For how NHGRI will treat new and non-competing applications, see the NHGRI Funding Policy.
NHGRI Funding Opportunities
- Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
RFA-HG-24-026
Application Due Date(s): November 15, 2024, August 1, 2024, July 31, 2026
Expiration Date: August 3, 2026
- ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)
RFA-HG-24-004
Application Due Date(s): July 26, 2024
Expiration Date: July 29, 2024- Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)": NOT-AG-24-019
- Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)": NOT-AG-24-019
- ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed)
RFA-HG-24-005
Application Due Date(s): July 26, 2024
Expiration Date: July 29, 2024
- Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
RFA-HG-23-033
Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025
Expiration Date: February 12, 2025
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
PAR-23-301
Application Due Date(s): February 16, 2024, June 16, 2024, October 16, 2024, February 16, 2025, June 16, 2025, October 16, 2025, February 16, 2026, June 16, 2026 and October 16, 2026
Expiration Date: January 8, 2027
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
RFA-HG-23-017
Application Due Date(s): November 08, 2023, July 08, 2024, July 08, 2025 (new); July 08, 2024 and July 08, 2025 (renewal)
Expiration Date: July 09, 2025
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
RFA-HG-23-018
Application Due Date(s): November 08, 2023, July 08, 2024, July 08, 2025 (new); July 08, 2024 and July 08, 2025 (renewal)
Expiration Date: July 09, 2025- Notice of Extension of the First Receipt Date of RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial (Clinical Trial Optional): NOT-HG-24-008
- Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional): NOT-HG-23-049
- Notice of Change to NHGRI-specific language in RFA-HG-23-018, Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional): NOT-HG-24-032
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
PAR-23-184
Application Due Dates: Applications are accepted by continuous receipt and are due by 5:00 PM local time of applicant organization.
Expiration Date: July 09, 2026
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
PAR-23-098
Application Due Date: June 23, 2023, June 21, 2024
Expiration Date: June 22, 2024
- Notice of Intent to Publish a Funding Opportunity Announcement for Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed): NOT-HG-23-028
- Diversity Centers for Genome Research (U54 Clinical Trials Optional)
RFA-HG-22-026
Application Due Dates: December 6, 2022; June 23, 2023; June 24, 2024
Expiration Date: June 25, 2024
- Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
RFA-HG-22-027
Application Due Dates: December 6, 2022; June 23, 2023; June 24, 2024
Expiration Date: June 25, 2024
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
PAR-22-107
Application Receipt Date(s): June 21, 2024
Expiration Date: June 22, 2024
- Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information
NOT-HG-22-011
- Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
PAR-21-254
Application Due Dates: February 5, June 5, October 5
Expiration Date: September 8, 2024- Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed): NOT-HG-24-033
- Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed): NOT-HG-24-033
- Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
PAR-21-255
Application Due Dates: February 16, June 16, October 16
Expiration Date: September 8, 2024- Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed): NOT-HG-24-034
- Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed): NOT-HG-24-034
- NHGRI’s Analysis, Visualization, and Informatics Lab-space (AnVIL) as an NIH-Designated Data Repository: NOT-HG-24-020
-
NHGRI Funding Opportunities
- Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
RFA-HG-24-026
Application Due Date(s): November 15, 2024, August 1, 2024, July 31, 2026
Expiration Date: August 3, 2026
- ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)
RFA-HG-24-004
Application Due Date(s): July 26, 2024
Expiration Date: July 29, 2024- Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)": NOT-AG-24-019
- Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)": NOT-AG-24-019
- ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed)
RFA-HG-24-005
Application Due Date(s): July 26, 2024
Expiration Date: July 29, 2024
- Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
RFA-HG-23-033
Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025
Expiration Date: February 12, 2025
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
PAR-23-301
Application Due Date(s): February 16, 2024, June 16, 2024, October 16, 2024, February 16, 2025, June 16, 2025, October 16, 2025, February 16, 2026, June 16, 2026 and October 16, 2026
Expiration Date: January 8, 2027
- Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
RFA-HG-23-017
Application Due Date(s): November 08, 2023, July 08, 2024, July 08, 2025 (new); July 08, 2024 and July 08, 2025 (renewal)
Expiration Date: July 09, 2025
- Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
RFA-HG-23-018
Application Due Date(s): November 08, 2023, July 08, 2024, July 08, 2025 (new); July 08, 2024 and July 08, 2025 (renewal)
Expiration Date: July 09, 2025- Notice of Extension of the First Receipt Date of RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial (Clinical Trial Optional): NOT-HG-24-008
- Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional): NOT-HG-23-049
- Notice of Change to NHGRI-specific language in RFA-HG-23-018, Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional): NOT-HG-24-032
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
PAR-23-184
Application Due Dates: Applications are accepted by continuous receipt and are due by 5:00 PM local time of applicant organization.
Expiration Date: July 09, 2026
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
PAR-23-098
Application Due Date: June 23, 2023, June 21, 2024
Expiration Date: June 22, 2024
- Notice of Intent to Publish a Funding Opportunity Announcement for Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed): NOT-HG-23-028
- Diversity Centers for Genome Research (U54 Clinical Trials Optional)
RFA-HG-22-026
Application Due Dates: December 6, 2022; June 23, 2023; June 24, 2024
Expiration Date: June 25, 2024
- Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
RFA-HG-22-027
Application Due Dates: December 6, 2022; June 23, 2023; June 24, 2024
Expiration Date: June 25, 2024
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
PAR-22-107
Application Receipt Date(s): June 21, 2024
Expiration Date: June 22, 2024
- Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information
NOT-HG-22-011
- Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
PAR-21-254
Application Due Dates: February 5, June 5, October 5
Expiration Date: September 8, 2024- Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed): NOT-HG-24-033
- Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed): NOT-HG-24-033
- Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
PAR-21-255
Application Due Dates: February 16, June 16, October 16
Expiration Date: September 8, 2024- Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed): NOT-HG-24-034
- Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed): NOT-HG-24-034
- NHGRI’s Analysis, Visualization, and Informatics Lab-space (AnVIL) as an NIH-Designated Data Repository: NOT-HG-24-020
- Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
NIH-Wide Parent Funding Opportunities
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
PA-23-217
Application Due Date(s): December 08, 2023, April 08, 2024, August 08, 2024​​​​​​, December 08, 2024, April 08, 2025​​​​​​​, August 08, 2025
Expiration Date: September 08, 2025​​​​​​​
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
PAR-21-357
Expiration Date: January 8, 2025
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
PAR-22-060
Expiration Date: January 8, 2025
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
PA-21-268
Expiration Date: June 30, 2024
- Plans to Promote Safe Environments at Conferences Supported by NIH Grants and Cooperative Agreements
NOT-OD-22-074
-
NIH-Wide Parent Funding Opportunities
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
PA-23-217
Application Due Date(s): December 08, 2023, April 08, 2024, August 08, 2024​​​​​​, December 08, 2024, April 08, 2025​​​​​​​, August 08, 2025
Expiration Date: September 08, 2025​​​​​​​
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
PAR-21-357
Expiration Date: January 8, 2025
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
PAR-22-060
Expiration Date: January 8, 2025
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
PA-21-268
Expiration Date: June 30, 2024
- Plans to Promote Safe Environments at Conferences Supported by NIH Grants and Cooperative Agreements
NOT-OD-22-074
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
NIH-Wide Topic Specific Funding Opportunities
- NOT-TR-23-026: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)
- PAR-23-124: Genomic Community Resources (U24 Clinical Trial Not Allowed)
Application Due Date(s): May 25, 2023, September 25, 2023, January 25, 2024, September 25, 2024, January 25, 2025, September 25, 2025, January 25, 2026
Expiration Date: January 26, 2026
- PAR-23-219: PAR-SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Application Due Date(s): September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, April 5, 2025
Expiration Date: April 6, 2024
- PAR-23-220: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
Application Due Date(s): September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, April 5, 2025
Expiration Date: April 6, 2024
- PAR-23-166: Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
Application Due Date(s): July 08, 2024, July 08, 2025, July 08, 2026
Expiration Date: August 08, 2026
- NOT-OD-23-106: Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy
- PAR-23-138: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- PAR-23-171: Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
Application Due Date(s): May 15, 2023, May 15, 2024, May 15, 2025
Expiration Date: May 16, 2025
- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
RFA-OD-22-028
Application Due Date(s): December 19, 2022, November 22, 2023; November 22, 2024
Expiration Date: November 23, 2024
- Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations
NOT-MD-22-012
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
PAR-22-105
Application Due Date(s): June 15, 2022, October 05, 2022, February 05, 2023, June 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, October 05, 2024, February 05, 2025
Expiration Date: May 8, 2025
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
PAR-22-106
Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, February 16, 2025, June 16, 2025
Expiration Date: September 8, 2025
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PAR-22-109
Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, October 16, 2024
Expiration Date: February 16, 2025
- Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) NOT-HL-23-001
- Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-21-345 Application Due Dates: Rolling
Expiration Date: September 10, 2024
- Announcing the High-Priority, Short-Term Project Award (R56)
- Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
NOT-HG-17-004 [grants.nih.gov]
- Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
-
NIH-Wide Topic Specific Funding Opportunities
- NOT-TR-23-026: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)
- PAR-23-124: Genomic Community Resources (U24 Clinical Trial Not Allowed)
Application Due Date(s): May 25, 2023, September 25, 2023, January 25, 2024, September 25, 2024, January 25, 2025, September 25, 2025, January 25, 2026
Expiration Date: January 26, 2026
- PAR-23-219: PAR-SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Application Due Date(s): September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, April 5, 2025
Expiration Date: April 6, 2024
- PAR-23-220: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
Application Due Date(s): September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, April 5, 2025
Expiration Date: April 6, 2024
- PAR-23-166: Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
Application Due Date(s): July 08, 2024, July 08, 2025, July 08, 2026
Expiration Date: August 08, 2026
- NOT-OD-23-106: Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy
- PAR-23-138: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- PAR-23-171: Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
Application Due Date(s): May 15, 2023, May 15, 2024, May 15, 2025
Expiration Date: May 16, 2025
- The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
RFA-OD-22-028
Application Due Date(s): December 19, 2022, November 22, 2023; November 22, 2024
Expiration Date: November 23, 2024
- Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations
NOT-MD-22-012
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
PAR-22-105
Application Due Date(s): June 15, 2022, October 05, 2022, February 05, 2023, June 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, October 05, 2024, February 05, 2025
Expiration Date: May 8, 2025
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
PAR-22-106
Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, February 16, 2025, June 16, 2025
Expiration Date: September 8, 2025
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PAR-22-109
Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, October 16, 2024
Expiration Date: February 16, 2025
- Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) NOT-HL-23-001
- Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-21-345 Application Due Dates: Rolling
Expiration Date: September 10, 2024
- Announcing the High-Priority, Short-Term Project Award (R56)
- Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
NOT-HG-17-004 [grants.nih.gov]
- Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
- NOT-TR-23-026: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)
Last updated: July 12, 2024